75%酒精湿敷治疗碘对比剂外渗的疗效:一项随机对照试验
该多中心随机对照试验纳入168例CECT中发生对比剂外渗的参与者,随机分为75%酒精湿敷组、50%硫酸镁湿敷组、0.05%地塞米松湿敷组和常规护理组。结果显示,75%酒精湿敷在肿胀消退方面与0.05%地塞米松湿敷等效且优于其他方法,并在疼痛缓解和生活质量改善方面表现更优。
要点
- 75%酒精湿敷在24、48、72小时肿胀消退75-100%的应答率与0.05%地塞米松湿敷无差异,且均显著高于硫酸镁湿敷和常规护理。
- 75%酒精湿敷的疼痛评分下降(ΔVAS 4.88)和生活质量评分下降(ΔDLQI 11.60)显著大于其他三组。
- 75%酒精湿敷为非甾体类无创处理,可作为对比剂外渗的治疗选择。
核心结论
- 75%酒精湿敷与0.05%地塞米松湿敷疗效相当,且优于其他对比剂外渗处理方法,能更有效缓解疼痛并改善生活质量。
研究设计与样本
- 随机对照试验,2019年2月1日至2023年7月1日在六家三级中心进行,纳入168例CECT中发生对比剂外渗的参与者,按1:1:1:1随机分为75%酒精湿敷组、50%硫酸镁湿敷组、0.05%地塞米松湿敷组和常规护理组。
诊断标准与关键数值
- 主要结局为肿胀面积从基线至4、24、48、72小时的百分比变化,分为<25%、25-50%、50-75%、75-100%四个等级;24、48、72小时时75%酒精湿敷组和0.05%地塞米松湿敷组肿胀消退75-100%的应答率显著高于50%硫酸镁湿敷组和常规护理组(均p<0.001),75%酒精湿敷组与0.05%地塞米松湿敷组之间无差异(均p>0.05)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the efficacy of 75% alcohol wet compression as a noninvasive treatment for contrast medium extravasation (CMEX) during contrast-enhanced computed tomography (CECT).
MATERIALS AND METHODS: This randomized controlled trial, conducted from February 1, 2019, to July 1, 2023, at six tertiary centers, involved participants undergoing CMEX during CECT. They were randomized (1:1:1:1) into four groups: 75% alcohol wet compress (AG), 50% magnesium sulfate wet compression (MG), 0.05% dexamethasone wet compression (DG), and routine care (RG). The primary outcome was the percentage change in the swelling area from baseline to 4 h, 24 h, 48 h, and 72 h, categorized as < 25%, 25-50%, 50-75%, and 75-100%. Secondary outcomes included pain reduction and quality of life improvement over 3 days, assessed using the visual analog pain intensity scale (VAS) and dermatology life quality index (DLQI), respectively.
RESULTS: Overall, 168 participants were randomized with balanced baseline characteristics. At 24 h, 48 h, and 72 h, AG and DG had significantly higher response rates (75-100%) than MG and RG (all p < 0.001), with no differences between AG and DG (all p > 0.05). AG showed greater reductions in pain score (ΔVAS: 4.88 vs 3.52 vs 3.29 vs 3.19, p < 0.001) and DLQI score (ΔDLQI: 11.60 vs 7.81 vs 7.86 vs 7.48, p < 0.001) than DG, MG, and RG.
CONCLUSION: The 75% alcohol wet compress was as effective as the 0.05% dexamethasone wet compression and superior to other CMEX treatment methods, providing more effective pain relief and improving the quality of life.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: ChiCTR2300067692.
KEY POINTS: Question Can 75% alcohol wet compression outperform standard treatments for CMEX in reducing swelling, alleviating pain, and improving quality of life? Findings Seventy-five percent alcohol compresses rival dexamethasone's efficacy while surpassing other treatments for pain and quality-of-life outcomes. Clinical relevance Seventy-five percent alcohol wet compression provides a steroid-free CMEX treatment, effectively resolving extravasation like dexamethasone while offering superior pain control and quality-of-life enhancement, potentially transforming clinical practice.
引用
- Wen X, Huang W, Liao C, et al. Efficacy of 75% alcohol wet compress therapy for iodinated contrast media extravasation: a randomized controlled trial. Eur Radiol. 2025. PMID: 40745054. doi:10.1007/s00330-025-11889-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。